Pfm Health Sciences, LP Arcutis Biotherapeutics, Inc. Transaction History
Pfm Health Sciences, LP
- $1.05 Billion
- Q2 2025
A detailed history of Pfm Health Sciences, LP transactions in Arcutis Biotherapeutics, Inc. stock. As of the latest transaction made, Pfm Health Sciences, LP holds 923,375 shares of ARQT stock, worth $13.6 Million. This represents 1.23% of its overall portfolio holdings.
Number of Shares
923,375Holding current value
$13.6 Million% of portfolio
1.23%Shares
1 transactions
Others Institutions Holding ARQT
# of Institutions
240Shares Held
129MCall Options Held
407KPut Options Held
216K-
Suvretta Capital Management, LLC New York, NY11.5MShares$170 Million5.56% of portfolio
-
Jennison Associates LLC11.1MShares$164 Million0.09% of portfolio
-
Rubric Capital Management LP New York, NY10.7MShares$158 Million3.47% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA9.87MShares$146 Million7.3% of portfolio
-
Black Rock Inc. New York, NY8.62MShares$127 Million0.0% of portfolio
About Arcutis Biotherapeutics, Inc.
- Ticker ARQT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 60,187,500
- Market Cap $887M
- Description
- Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. Its lead product candidate is ARQ-151, a topical roflumilast cream that has completed Phase III clinical trials for the treatment of plaque psoriasis and atopic dermatitis. The company is also developing A...